Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -48.04% is 13% above its 5-year average of -55.18%, near the high end of its 5-year range (-284.85%–-8.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 27.03% above its 12-month average of -65.83%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -48.04%.
RETURN ON INVESTED CAPITAL (ROIC)
-48.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-65.83%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-74.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-55.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+27.03%
CURRENT VS 3Y AVG
+35.65%
CURRENT VS 5Y AVG
+12.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 704 covered companies
CURRENT VS SECTOR MEDIAN
-42.12%
vs the sector median at left
Pasithea Therapeutics Corp.
Market Cap
$14.95M
Return on Invested Capital (ROIC)
-48.04%
TTM Avg
-65.83%
3Y Avg
-74.64%
5Y Avg
-55.18%
Market Cap
$15.08M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-183.21%
3Y Avg
-122.71%
5Y Avg
-100.21%
Market Cap
$15.42M
Return on Invested Capital (ROIC)
-497.29%
TTM Avg
-141.17%
3Y Avg
-111.65%
5Y Avg
-80.50%
Market Cap
$14.56M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.44M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-23.00%
3Y Avg
-25.06%
5Y Avg
-54.51%
Market Cap
$15.75M
Return on Invested Capital (ROIC)
-41.81%
TTM Avg
-159.62%
3Y Avg
-298.97%
5Y Avg
-203.41%
Market Cap
$13.97M
Return on Invested Capital (ROIC)
-57.53%
TTM Avg
-660.45%
3Y Avg
-553.22%
5Y Avg
-396.73%
Market Cap
$16.00M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
Market Cap
$13.88M
Return on Invested Capital (ROIC)
-67.62%
TTM Avg
-48.11%
3Y Avg
-41.05%
5Y Avg
-37.60%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $14.95M | -48.04% | -65.83% | -74.64% | -55.18% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.08M | N/A | -183.21% | -122.71% | -100.21% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | -497.29% | -141.17% | -111.65% | -80.50% |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.56M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | -13.15% | -23.00% | -25.06% | -54.51% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | -41.81% | -159.62% | -298.97% | -203.41% |
| Vyome Holdings, Inc. (HIND)vs › | $13.97M | -57.53% | -660.45% | -553.22% | -396.73% |
| BioCardia, Inc. (BCDA)vs › | $16.00M | -273.70% | -707.06% | -535.27% | -358.40% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.88M | -67.62% | -48.11% | -41.05% | -37.60% |
| IN8bio, Inc. (INAB)vs › | $13.89M | -91.74% | -119.31% | -112.64% | -88.90% |
ROIC
-48.0%
ROE
-42.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -48.04% |
| 2026-03-31 | -40.20% |
| 2025-12-31 | -37.74% |
| 2025-09-30 | -113.12% |
| 2025-06-30 | -90.07% |
| 2025-03-31 | -106.32% |
| 2024-12-31 | -95.35% |
| 2024-09-30 | -89.78% |
| 2024-06-30 | -104.03% |
| 2024-03-31 | -84.29% |
| 2023-12-31 | -68.05% |
| 2023-09-30 | -51.98% |
| 2023-06-30 | -41.44% |
| 2023-03-31 | -34.01% |
| 2022-12-31 | -29.07% |
| 2022-09-30 | -21.84% |
| 2022-06-30 | -15.21% |
| 2022-03-31 | -11.92% |
| 2021-12-31 | -8.52% |
| 2021-09-30 | -12.67% |
| 2021-06-30 | -284.85% |
